Sugal Damani Share Brokers Ltd vs Ttk Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Apr 18, 2026

Key Highlights

The Share Capital of Sugal & Damani Share Brokers Ltd is ₹ 6.25 crore as of 2025 .The Share Capital of Pet Stock Brokers Ltd is ₹ 0 crore as of 2025 .The Share Capital of TTK Healthcare Ltd is ₹ 0 crore as of 2025 . The Latest Trading Price of Sugal & Damani Share Brokers Ltd is ₹ 63.31 as of 17 Apr 15:30 . The P/E Ratio of Sugal & Damani Share Brokers Ltd is 7 as of March 2024 .The P/E Ratio of Pet Stock Brokers Ltd is 0 as of March 2024 .The P/E Ratio of TTK Healthcare Ltd is 0 as of March 2024 . The Market Cap of Sugal & Damani Share Brokers Ltd is ₹ 16.18 crore as of March 2024 .The Market Cap of Pet Stock Brokers Ltd is ₹ 0 crore as of March 2024 .The Market Cap of TTK Healthcare Ltd is ₹ 0 crore as of March 2024 . The revenue of Sugal & Damani Share Brokers Ltd for the Dec '25 is ₹ 2.44 crore as compare to the Sep '25 revenue of ₹ 6.17 crore. This represent the decline of -60.45% The revenue of Pet Stock Brokers Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of TTK Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Sugal & Damani Share Brokers Ltd for the Dec '25 is ₹ 0.25 crore as compare to the Sep '25 ebitda of ₹ 1.76 crore. This represent the decline of -85.8% The ebitda of Pet Stock Brokers Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of TTK Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Sugal & Damani Share Brokers Ltd changed from ₹ 1.44 crore to ₹ 0.16 crore over 7 quarters. This represents a CAGR of -71.51% The net profit of Pet Stock Brokers Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of TTK Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Sugal & Damani Share Brokers Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Pet Stock Brokers Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of TTK Healthcare Ltd changed from 18.26 % on March 2021 to 17.3 % on March 2025 . This represents a CAGR of -1.07% over 5 years .

About Sugal & Damani Share Brokers Ltd

Sugal & Damani Share Brokers Ltd (Formerly known as Sugal & Damani Finlease Ltd) was incorporated on 7th May, 1993.
It was entitled to commence business w.e.f. 17th May, 1993.
Post amalgamation, the Company's main business activities are Share broking, DP activity and Portfolio Management Services. SDSSBPL is a decade old and leading firm providing the entire gamut of financial services.
A Pioneer in the Indian capital markets, the Company launched its stock broking operations as a member of NSE India in 1995, promoted by a group of professional and experienced stockbrokers.
The firm, founded by G N Damani, Sugalchand Jain and Pravin B Chheda, today has a pan India presence as well as rich experience in different fields.

About TTK Healthcare Ltd

TTK Healthcare Limited, a TTK Group Company was incorporated in May 1958 as Orient Pharma and later renamed as TTK Pharma in Nov '81.
The Company is the owner of famous Woodwards Gripewater brand.
The Company operate into five main Strategic Business Units namely, Pharmaceuticals, Consumer Products, Medical Devices, Foods and Protective Devices divisions.
It is engaged into Animal Welfare Products, Consumer Products, Medical Devices, Protective Devices and Foods Businesses. In 1992, the company came out with a rights issue at a premium of Rs 35 aggregating Rs 5.81 cr to finance long-term working capital needs, normal capital expenditure, and product promotion. Products of TTK Healthcare include cardiac care systems, blood management systems, renal care systems, hospital accessories, antibiotics, Woodwards gripe water, animal medicines, etc.

FAQs for the comparison of Sugal & Damani Share Brokers Ltd and null

Which company has a larger market capitalization, Sugal & Damani Share Brokers Ltd or Pet Stock Brokers Ltd?

Market cap of Sugal & Damani Share Brokers Ltd is 39 Cr while Market cap of Pet Stock Brokers Ltd is 0 Cr

What are the key factors driving the stock performance of Sugal & Damani Share Brokers Ltd and Pet Stock Brokers Ltd?

The stock performance of Sugal & Damani Share Brokers Ltd and Pet Stock Brokers Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sugal & Damani Share Brokers Ltd and Pet Stock Brokers Ltd?

As of April 18, 2026, the Sugal & Damani Share Brokers Ltd stock price is INR ₹63.31. On the other hand, Pet Stock Brokers Ltd stock price is INR ₹0.0.

How do dividend payouts of Sugal & Damani Share Brokers Ltd and Pet Stock Brokers Ltd compare?

To compare the dividend payouts of Sugal & Damani Share Brokers Ltd and Pet Stock Brokers Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.